- Home
- CDNA vs ETWO Comparison
CDNA vs ETWO Comparison
Compare CDNA & ETWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- ETWO
- Stock Information
- Founded
- CDNA 1998
- ETWO 2000
- Country
- CDNA United States
- ETWO United States
- Employees
- CDNA N/A
- ETWO N/A
- Industry
- CDNA Medical Specialities
- ETWO EDP Services
- Sector
- CDNA Health Care
- ETWO Technology
- Exchange
- CDNA Nasdaq
- ETWO Nasdaq
- Market Cap
- CDNA 944.1M
- ETWO 930.2M
- IPO Year
- CDNA 2014
- ETWO N/A
- Fundamental
- Price
- CDNA $22.79
- ETWO $3.00
- Analyst Decision
- CDNA Buy
- ETWO Hold
- Analyst Count
- CDNA 8
- ETWO 3
- Target Price
- CDNA $27.17
- ETWO $3.90
- AVG Volume (30 Days)
- CDNA 816.5K
- ETWO 1.8M
- Earning Date
- CDNA 11-04-2024
- ETWO 01-07-2025
- Dividend Yield
- CDNA N/A
- ETWO N/A
- EPS Growth
- CDNA N/A
- ETWO N/A
- EPS
- CDNA N/A
- ETWO N/A
- Revenue
- CDNA $312,775,000.00
- ETWO $619,301,000.00
- Revenue This Year
- CDNA $19.60
- ETWO N/A
- Revenue Next Year
- CDNA $10.26
- ETWO $3.01
- P/E Ratio
- CDNA N/A
- ETWO N/A
- Revenue Growth
- CDNA 5.26
- ETWO N/A
- 52 Week Low
- CDNA $7.42
- ETWO $2.89
- 52 Week High
- CDNA $34.84
- ETWO $5.08
- Technical
- Relative Strength Index (RSI)
- CDNA 42.58
- ETWO 38.21
- Support Level
- CDNA $21.16
- ETWO $2.89
- Resistance Level
- CDNA $24.42
- ETWO $3.45
- Average True Range (ATR)
- CDNA 1.30
- ETWO 0.13
- MACD
- CDNA 0.16
- ETWO 0.01
- Stochastic Oscillator
- CDNA 43.83
- ETWO 18.75
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About ETWO E2open Parent Holdings Inc.Class A
E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority is from the Americas.